Markets

The victory gives Pfizer a long-awaited foothold in the booming weight-loss drug market as Novo retreats amid U.S. antitrust fears.

Today’s plunge, driven by panic and low liquidity rather than a systemic economic failure, is deceptively framed as a catastrophic …

🇻🇳 $21 Billion FDI Inflow Masks Alarming Corporate Mortality: Is Hanoi’s Recovery Sustainable? #Vietnam #Economy #Hanoi #MarketInsider

Vision Fund’s Pain Becomes the Market’s Lesson: Is The AI Rally Running on Hype, Not Profit?

Investors weigh mixed corporate results across the region while the Bank of England and Norway hold rates steady.

Ultra-wealthy investors pull back on volume but double down on artificial intelligence bets, fueling record valuations across the sector.

Asian Stocks Surge 2%: U.S. Jobs Boom Kills Rate-Cut Hopes